|Description||Brexpiprazole, a novel atypical antipsychotic drug, is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). It is approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. It is a close structural analog of aripiprazole and shares some of its pharmacological properties in vitro. It failed Phase II clinical trials for ADHD and was received FDA approval on July 13, 2015. It was developed by Otsuka and Lundbeck. It has been listed.|
|B0084-474906||1 g||$199||In stock|
|Synonyms||7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone;7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one;Rexulti;OPC-34712; OPC 34712; OPC34712|
|Solubility||DMSO: ≥ 48 mg/mL|
|Application||Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Quantity||Kilogram to ton|
|Boiling Point||675.2±55.0 °C | Condition: Press: 760 Torr|
|Density||1.245±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr|
|Current Developer||Brexpiprazole was developed by Otsuka and Lundbeck. It has been listed.|
ST-836, a dopamine receptor ligand, might have similar effect with dopamine and probably useful as an antiparkinsonian agent.
PD-120697 is a novel dopamine antagonist with central dopamine agonist properties. It was identified as orally active dopamine (DA) agonists with pronounced cen...
Metoclopramide is used mostly for stomach and esophageal problems by bind to dopamine D2 receptors with nanomolar affinity (Ki 28.8 nM)
Ziprasidone hydrochloride monohydrate
The hydrochloride monohydrate salt form of Ziprasidone, a benzothiazol derivative, has been found to be a 5HT2A and D2 receptor antagonist that could be used ag...
Levophacetoperane hydrochloride, a sympathomimetic central nervous system stimulant used to treat depression, inhibits in vitro in a competitive manner, norepin...
SKF 77434 hydrobromide
SKF 77434 hydrobromide is a selective dopamine D1-like receptor partial agonist (IC50 = 19.7 and 2425 nM for binding to D1-like and D2-like receptors, respectiv...
Pridopidine, also known as ACR16, is a dopamine stabilizer used in the treatment of neurologic and psychiatric disorders.
PPHT hydrochloride is a potent and selective D2 agonist.